Loading...
Market
What will be the US government's future actions against Chinese biotech firms by December 31, 2024?
5
China•FBI•ODNI•Chinese•GenScript•Chinese Communist Party•CCP•John Moolenaar•Raja Krishnamoorthi•Legend Biotech
Resolution / Starting Odds
More firms investigated • 25%
Sanctions imposed • 25%
No significant actions • 25%
Other actions • 25%
Official US government announcements or policies
Story
House China Panel Seeks FBI, ODNI Briefing on GenScript's CCP Links
May 31, 2024, 07:02 PM
The U.S. House of Representatives committee on China has requested a briefing from the FBI and the Office of the Director of National Intelligence (ODNI) on the activities of Chinese biotech firm GenScript and its connections to the Chinese Communist Party (CCP). The committee, led by Chairman Rep. John Moolenaar and Ranking Member Rep. Raja Krishnamoorthi, is particularly concerned about GenScript's role in establishing CCP-controlled chokepoints in critical areas of the biotechnology industry. This request marks an expansion of the committee's focus from contract research organizations (CROs) and national security to include therapeutics developers and commercial competitiveness, including Legend Biotech.
View original story
Similar markets
Support U.S. Actions • 33%
Oppose U.S. Actions • 33%
Remain Neutral • 34%
Follow U.S. policy • 33%
Reject U.S. policy • 33%
Stay neutral • 33%
Yes • 50%
No • 50%
Significant decline in market value • 33%
Minor impact on market value • 33%
No impact on market value • 34%
Pfizer • 20%
Moderna • 20%
Gilead Sciences • 20%
Biogen • 20%
No major announcements • 20%
